Risk Factors for Hypertension in Patients with Stroke Presenting to Tertiary Care Hospital
DOI:
https://doi.org/10.37762/jgmds.10-4.469Keywords:
Stroke, Hypertension, Risk factorsAbstract
OBJECTIVES
To determine the risk factors for hypertension in stroke patients presenting to the tertiary care hospital of Peshawar, Pakistan.
METHODOLOGY
This cross-sectional descriptive study was conducted in the Department of Medicine at Khyber Teaching Hospital, Peshawar. This study spanned months and included 225 patients of either gender who had stroke symptoms within the preceding 72 hours. Detailed information was documented in age (in years), residence, gender, educational qualification, family history of hypertension, smoking, diabetes mellitus, obesity, dyslipidemia, hypertension, and duration. SPSS version 26.0 was used.
RESULTS
The age range of the participants were from 41 to 80 years, with a mean age of 61.004±6.69. The mean duration of hypertension was 3.052±0.85 years. Hypertension was seen in 42.2% of patients. Factors leading to hypertension in stroke patients were age 40.8%, urban area 42%, illiteracy 36.2%, positive family history 61.9%, diabetes mellitus 65.2%, smoking 33.3%, obesity 85.3%, and dyslipidemia 71.8%.
CONCLUSION
Significant risk factors for stroke include hypertension, diabetes mellitus, hypercholesterolemia, smoking, obesity, and positive family history.
Downloads
Metrics
References
Tsarkov A, Petlovanyi P. Neuropsychiatric aspects of a common problem: Stroke. European Journal of Medical and Health Sciences. 2019;1(3)
Mensah GA, Roth GA, Fuster V. The global burden of cardiovascular diseases and risk factors: 2020 and beyond. J Am Coll Cardiol. 2019;74(20):2529–32.
Katan M, Luft A. Global burden of stroke. Semin Neurol. 2018;38(2):208–11
Fisher, N.D. and Curfman, G., 2018. Hypertension—a public health challenge of global proportions. JAMA, 320(17), pp.1757-9
Moothedath S, Joseph V. Effectiveness of an educational intervention programme on knowledge, attitude and practice of school children regarding prevention of hypertension. Indian J Public Health Res Dev. 2019;10(8):515
Khan MI. The epidemiology of stroke in a developing country (Pakistan). J Neurol Stroke. 2018;8(1)
Hossain M, Rimon RH, Islam MA, Jamil MS, Raihan MA, Choudhury A. The Frequency and Location of Hemorrhage and Infarction in Stroke Patients Having Hypertension by Computed Tomography (C). CT) Scan Fortune Journal of Health Sciences. 2022;5(2):296–309
Juma K, A. Juma P, Shumba C, Otieno P, Asiki G. Non-communicable diseases and urbanization in African cities: A narrative review. In: Public Health in Developing Countries - Challenges and Opportunities. IntechOpen; 2020.
Wajngarten M, Silva GS. Hypertension and stroke: Update on treatment. Eur Cardiol. 2019;14(2):111–5
Woodward M. Cardiovascular disease and the female disadvantage. Int J Environ Res Public Health. 2019;16(7):1165
Ilunga Tshiswaka D, Ibe-Lamberts KD, Fazio M, Morgan JD, Cook C, Memiah P. Determinants of stroke prevalence in the southeastern region of the United States. Z Gesundh Wiss. 2019;27(4):435–42
Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, et al. Heart disease and stroke statistics—2019 update: A report from the American heart association. Circulation. 2019;139(10).
Farooq A, Venketasubramanian N, Wasay M. Stroke care in Pakistan. Cerebrovasc Dis Extra. 2021;11(3):118–21
Sherin A, Ul-Haq Z, Fazid S, Shah BH, Khattak MI, Nabi F. Prevalence of stroke in Pakistan: Findings from Khyber Pakhtunkhwa integrated population health survey (KP-IPHS) 2016-17. Pak J Med Sci Q. 2020;36(7):1435–40
Wnuk M, Popiela T, Drabik L, Brzegowy P, Lasocha B, Wloch-Kopec D, et al. Fasting hyperglycemia and long-term outcome in patients with acute ischemic stroke treated with mechanical thrombectomy. J Stroke Cerebrovasc Dis. 2020;29(5):104774
Meng-Ke ZH, Zh W-B, Ji X-M. Research progress in the affect of cerebral microbleeds on clinical efficacy of ischemic stroke. Chinese Journal of Contemporary Neurology & Neurosurgery. 2021;21(10)
Anderson CS, Huang Y, Lindley RI, Chen X, Arima H, Chen G, et al. Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomized, open-label, blinded-endpoint, phase 3 trial. The Lancet. 2019;393:877–88
Aurelius T, Ken-Dror G, Sharma SD, Amlani S, Gunathilagan G, Cohen DL, et al. Atrial fibrillation in UK South Asian hospitalized ischemic stroke patients: The BRAINS study. PLoS One. 2023;18(2):e0281014
Mansoor R, Lodhi MW, Zafar H, Haider S, Sattar RA. Iron Deficiency Anemia Predisposing to Acute Ischemic Stroke-Is there a Need for a more Aggressive Approach? Archives of Internal Medicine Research. 2022;5(4):466–70.
O'donnell M, Hankey GJ, Rangarajan S, Chin SL, Rao-Melacini P, Ferguson J, et al. Variations in knowledge, awareness and treatment of hypertension and stroke risk by country income level. Heart. 2021;107(4):282–9
Andersson C, Johnson AD, Benjamin EJ, Levy D, Vasan RS. 70-year legacy of the Framingham Heart Study. Nat Rev Cardiol. 2019;16(11):687–98
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Iqbal Haider, Aliena Badshah, Shafaat Ur Rahman, Maaz Ullah, Muhammad Fayyaz, Wazir Mohammad
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
